Literature DB >> 8827177

Neuroepidemiology of HIV infection.

G J Dal Pan1, J C McArthur.   

Abstract

There are a variety of HIV-related neurologic complications that have numerous causes. HIV-related neurologic illnesses are specific to the stage of HIV infection, although the greatest burden of neurologic disease and the most disabling syndromes occur in the more advanced stages. As the number of HIV-infected persons continues to increase worldwide and as antiretroviral and other anti-infective therapies improve patient survival in the advanced stages of HIV infection, the burden of neurologic disease will continue to increase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827177     DOI: 10.1016/s0733-8619(05)70262-0

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  3 in total

1.  Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis.

Authors:  Sérgio Monteiro de Almeida; Kátia Boritza; Laura Lucia Cogo; Luis Pessa; João França; Indianara Rota; Marisol Muro; Cléa Ribeiro; Sonia Mara Raboni; Luine Rosele Vidal; Meri Bordignon Nogueira; Ronald Ellis
Journal:  Clin Chem Lab Med       Date:  2011-02-11       Impact factor: 3.694

2.  Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment.

Authors:  Clayton A Wiley; Brian J Lopresti; James T Becker; Fernando Boada; Oscar L Lopez; John Mellors; Carolyn C Meltzer; Stephen R Wisniewski; Chester A Mathis
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

3.  Differential Survival for Men and Women with HIV/AIDS-Related Neurologic Diagnoses.

Authors:  Martha L Carvour; Jerald P Harms; Charles F Lynch; Randall R Mayer; Jeffery L Meier; Dawei Liu; James C Torner
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.